FDA Adverse Event Injury Summary report: N

COLOGUARD

MDR report key: 15886006 · Received November 29, 2022

Report

Report Number
MW5113531
Event Type
Injury
Date Received
November 29, 2022
Date of Event
November 9, 2022
Report Date
November 26, 2022
Manufacturer
EXACT SCIENCE CORPORATION
Product Code
PHP
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
MA, US
Reporter Occupation
PATIENT
Health Professional
*

Narratives

Description of Event or Problem · 0

I AM WRITING TO MAKE YOU AWARE OF MY EXPERIENCE WITH THE COLOGUARD TEST, WHICH I TOOK IN MID (B)(6) 2021. IT WAS SUPPOSED TO BE GOOD FOR THREE YEARS. MY DOCTOR SAID I WAS A GOOD CANDIDATE, BECAUSE I HAVE NOT HAD ANY HISTORY OF COLON CANCER IN MY FAMILY. SHE EXPLAINED TO ME THESE TESTS ARE HIGHLY SENSITIVE, AND SHOULD PICK UP ON ANY TRACE OF COLON CANCER, AND I TRUSTED THIS. THIS YEAR, I HAD SIGNIFICANT WEIGHT LOSS AND MY GASTROENTEROLOGIST ADVISED ME TO HAVE A DIAGNOSTIC COLONOSCOPY. IT ENDED UP THAT I HAD A TUBULAR ADENOMA (PRECANCEROUS POLYP). IF I HAD WAITED ANOTHER TWO YEARS FOR A REPEAT COLOGUARD TEST, I WOULD HAVE HAD COLON CANCER AT THAT POINT, AS THIS IS DOCUMENTED IN MY GASTROENTEROLOGIST'S NOTES. THIS IS UNACCEPTABLE, AS I HAVE SPENT A LOT OF MONEY ON A DIAGNOSTIC COLONOSCOPY. I REALIZE THERE IS A DISCLAIMER WITH THIS TEST THAT IT IS NOT 100% ACCURATE, BUT THE TIME FRAME WAS JUST BARELY OVER A YEAR, NOT THREE. THIS IS UNACCEPTABLE, AS I COULD HAVE HAD A PREVENTATIVE COLONOSCOPY, WHICH WOULD HAVE COST ME NOTHING AND DETECTED MY TUBULAR ADENOMA A LOT SOONER. I HAVE TO NOW HAVE A REPEAT COLONOSCOPY IN 3 YEARS AND THIS COULD HAVE ALL BEEN PREVENTED. I CONTACTED THE COMPANY AND THEY ARE NOT WILLING TO ACCEPT ANY RESPONSIBILITY.

Description of Event or Problem · 0

ADDITIONAL INFORMATION RECEIVED FROM REPORTER ON 01/12/2023 FOR MW5113531. HER ABDOMINAL SYMPTOMS HAVE RESOLVED AND IS NO LONGER PROBLEM. SHE IS HAVING NORMAL BOWEL MOVEMENTS WHICH IS GREAT. HER COLONOSCOPY SHOWED A DECENT SIZE POLYP IN HER SIGMOID COLON WHICH WAS A TUBULAR ADENOMA. THIS IS INTERESTING CONSIDERING A NEGATIVE COLOGUARD ABOUT A YEAR AGO. THIS IS THE EXACT REASON WHY WE FAVOR A SCREENING COLONOSCOPY OVER COLOGUARD WITH THE FACT THAT 8% OF PATIENTS WITH POLYPS COULD END UP HAVING A NEGATIVE COLOGUARD. FOR EXAMPLE, IF THIS PATIENT DID NOT HAVE A COLONOSCOPY, SHE COULD CERTAINLY END UP WITH COLON CANCER IN THE NEXT FEW YEARS. I HAVE NOW RECOMMENDED HER COLONOSCOPY TO BE REPEATED IN 3 YEARS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2329820 COLOGUARD SYSTEM, COLORECTAL NEOPLASIA, DNA METHYLATION AND HEMOGLOBIN DETECTION PHP EXACT SCIENCE CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 57 YR Female Required Intervention